Respiratory Syncytial Virus Disease

• CLINICAL_TRIALS trial_result · 2026-08-18
  Clinical Trial Results: A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus [Phase 2]

  Phase 2 trial results for an mRNA-1345 vaccine targeting Respiratory Syncytial Virus in children aged 2 to <18 at high risk; results complet…

• CLINICAL_TRIALS trial_result · 2026-07-02
  Clinical Trial Results: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants [Phase 3]

  Phase 3 study assessing RSVpreF vaccine in pregnant participants with HIV and their infants; results completed with posted findings.

• CLINICAL_TRIALS trial_result · 2025-02-03
  Clinical Trial Update: A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older [Phase 1]

  A Phase 1 trial evaluating a single vaccination of an Ad26.preF-based RSV vaccine in healthy Japanese adults aged 60 years and older has com…

• CLINICAL_TRIALS trial_result · 2023-10-27
  Clinical Trial Update: Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age [Phase 3]

  Phase 3 trial update reporting safety and immunogenicity of RSVpreF coadministered with SIIV in adults aged 65 and older; results posted.

• CLINICAL_TRIALS trial_result · 2023-04-12
  Clinical Trial Update: Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age [Phase 3]

  Phase 3 trial update on lot-to-lot consistency for an RSV vaccine (RSVpreF) in healthy adults aged 18 to 49.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-01-05
  Clinical Trial Update: MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States [Phase 3]

  Phase 3 trial of MEDI-524 (motavizumab) for RSV prevention in Native American infants completed; results posted in 2022.

• CLINICAL_TRIALS trial_result · 2020-10-23
  Clinical Trial Update: Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults [Phase 1]

  Phase 1 trial update evaluating a stabilized RSV F subunit vaccine with or without alum, focusing on dose, safety, tolerability, and immunog…

• CLINICAL_TRIALS trial_result · 2020-05-27
  Clinical Trial Update: Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children [Phase 2]

  Phase 2 pilot trial evaluating azithromycin for RSV-induced respiratory failure in children has completed with results posted.

• CLINICAL_TRIALS research · 2019-02-15
  Clinical Trial Update: A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age [NA]

  Prospective epidemiological study assessing RSV disease burden in newborns and risk of wheeze/asthma up to age 6.

• CLINICAL_TRIALS trial_result · 2018-11-28
  Clinical Trial Update: Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection [Phase 2]

  Phase 2 clinical trial update for presatovir in lung transplant recipients with RSV infection completed, with results posted in 2018.